REPORT HIGHLIGHT
Primary Cell Culture Market size was valued at USD 4,021.8 Million in 2022, expanding at a CAGR of 11.2% from 2023 to 2030.
A laboratory procedure known as primary cell culture is used to develop and research cells that have been derived directly from living organisms, generally from tissues or organs. These cells are stated to as primary as they are extracted straight from the source without going through a lengthy passaging process.
Primary Cell Culture Market- Market Dynamics:
Growing developments in biotechnology and cell culture technologies is expected to propel the primary cell culture demand.
Primary cell culture is now more accessible, effective, and economical because to ongoing advancements in biotechnology and cell culture technologies. The use of primary cell culture in research and development has been expanded because of these developments. In the pharmaceutical business, primary cell culture models are frequently employed to evaluate and test new drug candidates. They are now used more frequently in drug discovery and development than standard cell lines because they provide more accurate drug response predictions. Furthermore, better disease models are required to understand the mechanisms underlying chronic diseases including cancer, cardiovascular problems, and neurological ailments and develop appropriate treatments.
The demand for primary cell culturing techniques has increased as personalized medicine and targeted therapeutics come into greater emphasis. Primary cell cultures are crucial tools for drug research, toxicity testing, and disease modelling because they provide a more precise depiction of the biology of specific patients.
Primary Cell Culture Market- Key Insights:
- As per the analysis shared by our research analyst, the global Primary Cell Culture market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2023-2030)
- The Primary Cell Culture industry is projected to grow at a significant rate due to the growing focus on animal health and nutrition.
- Based on Product, primary cells segment was predicted to show maximum market share in the year 2022.
- Based on Application, cell & gene therapy development segment is expected to hold significant market share by 2030.
- Based on Cell Type segmentation, animal cells segment was the leading in 2022
- On the basis of region, North America was the leading revenue generator in 2022.
Primary Cell Culture Market- Segmentation Analysis:
The Global Primary Cell Culture Market is segmented on the basis of Type, Product, Application, and Region.
The market is divided into two categories based on Cell Type: animal cells and human cells. The animal cells segment dominates the market. Increasing demand for understanding infections is contributing to market growth.
The market is divided into two categories based on Product: primary cells, and reagents & supplements. The polyethylene segment dominates the market. Increasing demand from plastic & packaging industries is expected to boost the market growth.
The market is divided into five categories based on Application: cell & gene therapy development, vaccine production, virology, prenatal diagnosis, and others. The cell & gene therapy development segment dominates the market. The rising demand from gene therapy treatment is increasing the segment growth.
Primary Cell Culture Market- Geographical Insights:
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Primary Cell Culture Market- Competitive Landscape:
Owing to the increasing development in healthcare, and rising demand from medical sector, which influence the primary cell culture market. Several distribution channels, including corporate websites, and products, are used by businesses to sell their solutions & products. Product manufacturers compete on various factors, such as cell development, treating diseases. reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and expand their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.
Recent Developments:
In February 2023, Thermo Fisher Scientific, Inc. announced a collaboration with Celltrio, a manufacturing company to enable a fully automated cell culture system.
Key features of the study:
- This proposed research study on Primary Cell Culture market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Primary Cell Culture market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Primary Cell Culture market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Primary Cell Culture market
- Impact of COVID-19 on Primary Cell Culture market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Primary Cell Culture market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Primary Cell Culture market, we have also included competitive landscape and key innovator analysis for the Primary Cell Culture market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial inspection and strategic initiatives of players operating in the Primary Cell Culture market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Primary Cell Culture market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PRIMARY CELL CULTURE MARKET KEY PLAYERS
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Lonza Group Ltd.
- Corning Incorporated
- GE Healthcare
- Sartorius AG
- Promega Corporation
- Charles River Laboratories International, Inc.
- Cytiva
- CellGenix GmbH
- ZenBio, Inc.
- PromoCell GmbH
- STEMCELL Technologies, Inc.
- Takara Bio, Inc.
- Irvine Scientific
GLOBAL PRIMARY CELL CULTURE MARKET, BY CELL TYPE
GLOBAL PRIMARY CELL CULTURE MARKET, BY PRODUCT
- Primary cells
- Reagents & supplements
GLOBAL PRIMARY CELL CULTURE MARKET, BY APPLICATION
- Cell & Gene Therapy Development
- Vaccine Production
- Virology
- Prenatal Diagnosis
- Others
GLOBAL PRIMARY CELL CULTURE MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA